Krishna Institute of Medical Sciences Future Growth
Future criteria checks 3/6
Krishna Institute of Medical Sciences is forecast to grow earnings and revenue by 18.8% and 18.4% per annum respectively. EPS is expected to grow by 18.7% per annum. Return on equity is forecast to be 19.3% in 3 years.
Key information
18.8%
Earnings growth rate
18.7%
EPS growth rate
Healthcare earnings growth | 25.6% |
Revenue growth rate | 18.4% |
Future return on equity | 19.3% |
Analyst coverage | Good |
Last updated | 18 Jul 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 45,224 | 5,734 | 3,827 | 9,033 | 4 |
3/31/2026 | 35,546 | 4,426 | 2,636 | 7,442 | 10 |
3/31/2025 | 29,604 | 3,746 | -1,747 | 6,198 | 10 |
3/31/2024 | 24,981 | 3,101 | -1,262 | 5,211 | N/A |
12/31/2023 | 24,403 | 3,379 | N/A | N/A | N/A |
9/30/2023 | 23,966 | 3,421 | -2,263 | 4,621 | N/A |
6/30/2023 | 23,082 | 3,472 | N/A | N/A | N/A |
3/31/2023 | 21,977 | 3,363 | -1,424 | 4,321 | N/A |
12/31/2022 | 19,941 | 3,237 | N/A | N/A | N/A |
9/30/2022 | 18,255 | 3,289 | 741 | 3,693 | N/A |
6/30/2022 | 16,732 | 3,135 | N/A | N/A | N/A |
3/31/2022 | 16,508 | 3,327 | 1,537 | 3,240 | N/A |
12/31/2021 | 16,370 | 3,098 | N/A | N/A | N/A |
9/30/2021 | 16,041 | 2,774 | 2,318 | 3,488 | N/A |
6/30/2021 | 16,020 | 2,792 | N/A | N/A | N/A |
3/31/2021 | 13,299 | 2,012 | 2,615 | 3,560 | N/A |
12/31/2020 | 12,412 | 1,721 | 3,180 | 3,774 | N/A |
3/31/2020 | 11,227 | 1,192 | 1,495 | 2,015 | N/A |
3/31/2019 | 9,204 | -477 | 566 | 1,339 | N/A |
3/31/2018 | 6,652 | -474 | 473 | 1,058 | N/A |
3/31/2017 | 5,689 | 326 | N/A | 815 | N/A |
3/31/2016 | 5,145 | 266 | N/A | 955 | N/A |
3/31/2015 | 4,222 | 56 | N/A | 639 | N/A |
3/31/2014 | 3,569 | 69 | N/A | 778 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 543308's forecast earnings growth (18.8% per year) is above the savings rate (6.7%).
Earnings vs Market: 543308's earnings (18.8% per year) are forecast to grow faster than the Indian market (16% per year).
High Growth Earnings: 543308's earnings are forecast to grow, but not significantly.
Revenue vs Market: 543308's revenue (18.4% per year) is forecast to grow faster than the Indian market (9.5% per year).
High Growth Revenue: 543308's revenue (18.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 543308's Return on Equity is forecast to be low in 3 years time (19.3%).